| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $23.7M | +3.6% |
| SG&A Expense | $10.7M | -47.7% |
| Operating Income | -$34.4M | +47.9% |
| Pre-tax Income | -$36.1M | +46.0% |
| Income Tax | $0 | — |
| Net Income | -$36.1M | +46.0% |
| EPS (Basic) | -$16.65 | +56.4% |
| EPS (Diluted) | -$16.65 | +56.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.2M | -54.6% |
| Current Assets | $20.1M | -53.7% |
| Total Assets | $21.1M | -53.2% |
| Current Liabilities | $23.1M | +132.0% |
| Long-term Debt | $11.7M | +4.8% |
| Total Liabilities | $31.8M | +39.7% |
| Stockholders' Equity | -$10.7M | -147.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.8M | +9.0% |
| Capital Expenditures | $66K | -25.8% |
| Investing Cash Flow | -$66K | -103.2% |
| Financing Cash Flow | $8.8M | -82.6% |
| Free Cash Flow | -$31.9M | +9.1% |